Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure
- PMID: 7247557
- DOI: 10.1016/s0003-4975(10)61368-9
Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure
Abstract
Ninety-nine patients with Stage I or II lung carcinoma that was other than the small cell type and who survived for more than 30 days after a "curative" resection were followed for five years or until death if it occurred prior to the five-year anniversary. Recurrent disease developed in 44 patients. Clinical data and data from postmortem examination were reviewed in these 44 patients in an attempt to classify each recurrence as either initially local or distinct metastatic disease. The site of the first documented recurrence was local in 18 patients and distance metastases in 26. When the patients with recurrence were separated into TNM categories, it was apparent that in those patients without lymph nodes metastases demonstrated in the resected specimen (N0), the initial recurrence tended to be a distant metastases, whereas in those with such involvement (N1), the initial occurrence was more often local. In light of these data, selection of appropriate initial adjuvant therapeutic modalities may be different for each type of patient.
Similar articles
-
Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.J Thorac Oncol. 2012 Jul;7(7):1115-23. doi: 10.1097/JTO.0b013e31824cbad8. J Thorac Oncol. 2012. PMID: 22592210
-
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.Cancer. 1996 Jun 1;77(11):2393-9. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2393::AID-CNCR31>3.0.CO;2-Q. Cancer. 1996. PMID: 8635112 Clinical Trial.
-
Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.Lung Cancer. 2018 Jan;115:28-33. doi: 10.1016/j.lungcan.2017.11.014. Epub 2017 Nov 16. Lung Cancer. 2018. PMID: 29290258
-
The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.Thyroid. 2012 Nov;22(11):1144-52. doi: 10.1089/thy.2012.0043. Epub 2012 Oct 19. Thyroid. 2012. PMID: 23083442 Review.
-
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.J Thorac Oncol. 2015 Dec;10(12):1675-84. doi: 10.1097/JTO.0000000000000678. J Thorac Oncol. 2015. PMID: 26709477 Review.
Cited by
-
Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.Ann Surg. 1987 Jan;205(1):67-71. doi: 10.1097/00000658-198701000-00012. Ann Surg. 1987. PMID: 3026260 Free PMC article.
-
Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection.Int J Clin Oncol. 2005 Dec;10(6):425-8. doi: 10.1007/s10147-005-0526-5. Int J Clin Oncol. 2005. PMID: 16369747
-
Epidemiology of lung cancer prognosis: quantity and quality of life.Methods Mol Biol. 2009;471:469-86. doi: 10.1007/978-1-59745-416-2_24. Methods Mol Biol. 2009. PMID: 19109795 Free PMC article.
-
Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer.Thorax. 1988 Nov;43(11):883-6. doi: 10.1136/thx.43.11.883. Thorax. 1988. PMID: 2851880 Free PMC article.
-
Stereotactic body radiotherapy (SBRT) for T2N0 (>3 cm) non-small cell lung cancer: Outcomes and failure patterns.J Radiosurg SBRT. 2021;7(4):271-277. J Radiosurg SBRT. 2021. PMID: 34631228 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical